As the largest family of receptor tyrosine kinases, the EPH receptors have been found to be overexpressed in a number of human cancers (12,13) and studies have shown that EPH receptors and their ligands are crucial in tumor progression (14,15). This evidence concerns the gene NTRK1 and neoplasm.